An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.
Some experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Service Reaction and Material Removal
Based on TikTok, the service has taken down violative material and prohibited related keywords and query recommendations. The company stated it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with images of slimming results, positive reviews and detailed instructions for preparing or administering at residence.
Within minutes of joining one community, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Product Details and Costs
Within these communities, posts display black plastic parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially significant health risks”.
